Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids

被引:134
作者
Petschow, BW
Batema, RP
Ford, LL
机构
关键词
D O I
10.1128/AAC.40.2.302
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previous studies have shown that various short- and medium-chain free fatty acids (FFAs) and their corresponding monoacylglycerol esters (MGs) have antibacterial activity in vitro against primarily gram-positive bacteria, More recent studies have also shown that the growth of Helicobacter spp, is inhibited by linoleic acid and arachidonic acid. The purpose of the present study was to evaluate the susceptibility of Helicobacter pylori to the in vitro bactericidal properties of medium-chain MGs and FFAs, Incubation of H. pylori with saturated MGs, ranging in carbon chain length from C-10:0 to C-14:0, at 1 mM caused a 4-log-unit or greater reduction in the number of viable bacteria after exposure for 1 h. Lower levels of bactericidal activity were observed with C-9:0, C-15:0, and C-16:0 MGs. In contrast, lauric acid (C-12:0) was the only medium-chain saturated FFA with bactericidal activity against H. pylori. The MGs and FFAs were bactericidal after incubation for as little as 15 min at neutral or acidic pHs, Higher levels of MGs and FFAs were required for bactericidal activity in the presence of higher amounts of protein in liquid diets. We also found that the frequency of spontaneous development of resistance by H. pylori was higher for metronidazole and tetracycline (10(-5) to 10(-6)) than for C-10:0 MG, C-12:0, MG, and C-12:0 FFA (<10(-8)). Collectively, our data demonstrate that H. pylori is rapidly inactivated by medium-chain MGs and lauric acid and exhibits a relatively low frequency of spontaneous development of resistance to the bactericidal activity of MGs, Further studies are needed to establish whether MGs may be useful either alone or with other known therapeutic agents in the management of H. pylori infections in humans.
引用
收藏
页码:302 / 306
页数:5
相关论文
共 30 条
[21]  
MARSHALL BJ, 1993, GASTROENTEROL CLIN N, V22, P183
[22]   HELICOBACTER-PYLORI AND PEPTIC-ULCERS - THE PRESENT POSITION [J].
MOSS, S ;
CALAM, J .
GUT, 1992, 33 (03) :289-292
[23]   INFLUENCE OF TRACE AMOUNTS OF FATTY ACIDS ON THE GROWTH OF MICROORGANISMS [J].
NIEMAN, C .
BACTERIOLOGICAL REVIEWS, 1954, 18 (02) :147-163
[24]  
PENSTON JG, 1994, ALIMENT PHARM THER, V8, P369
[25]   CAMPYLOBACTER-PYLORIDIS-ASSOCIATED CHRONIC ACTIVE ANTRAL GASTRITIS - A PROSPECTIVE-STUDY OF ITS PREVALENCE AND THE EFFECTS OF ANTIBACTERIAL AND ANTIULCER TREATMENT [J].
RAUWS, EA ;
LANGENBERG, W ;
HOUTHOFF, HJ ;
ZANEN, HC ;
TYTGAT, GNJ .
GASTROENTEROLOGY, 1988, 94 (01) :33-40
[26]   THE SUSCEPTIBILITY OF HELICOBACTER-PYLORI TO 12 ANTIMICROBIAL AGENTS, OMEPRAZOLE AND BISMUTH SALTS [J].
RUBINSTEIN, G ;
DUNKIN, K ;
HOWARD, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (03) :409-413
[27]   LIPOPOLYSACCHARIDE LAYER PROTECTION OF GRAM-NEGATIVE BACTERIA AGAINST INHIBITION BY LONG-CHAIN FATTY-ACIDS [J].
SHEU, CW ;
FREESE, E .
JOURNAL OF BACTERIOLOGY, 1973, 115 (03) :869-875
[28]  
Shibasaki I., 1978, PHARM EFFECTS LIPIDS, P1
[29]   INHIBITORY EFFECT OF POLYUNSATURATED FATTY-ACIDS ON THE GROWTH OF HELICOBACTER-PYLORI - A POSSIBLE EXPLANATION OF THE EFFECT OF DIET ON PEPTIC-ULCERATION [J].
THOMPSON, L ;
COCKAYNE, A ;
SPILLER, RC .
GUT, 1994, 35 (11) :1557-1561
[30]  
1985, METHODS DILUTION ANT